Skip to content

Author

Fenghao Peng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Development and clinical application of recombinant polyclonal antibodies

Monoclonal antibodies (mAbs) have transformed the treatment of cancer and immune disorders, but their single-target nature limits efficacy against heterogeneous tumors and mutating pathogens. Recombinant polyclonal antibodies (RPABs)—defined as mixtures of typically 2–25 defined mAbs produced as a single drug substance...

Jiaqi Jin, Guo-Jiang Chen, Fenghao Peng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.